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Summary. Cytomegalovirus (CMV) is a typical 
pathogen of an opportunistic infection. In this review 
article, various roles of nitric oxide (NO) in murine 
CMV (MCMV) infections, including acute, persistent 
and latent infections, are discussed. In the acute phase of 
MCMV infection, NO plays a protective role against 
MCMV infection. In contrast, NO has been proven to act 
as a pathogenic factor in a model of MCMV 
pneumonitis. In MCMV persistent infection, when 
MCMV was detected only in the salivary gland, T cells 
of mice were modified to produce a massive amount of 
such cytokines as T N F - a  and IFN-y upon in vivo 
stimulation with anti-CD3. These cytokines then induced 
mRNA for inducible NO synthase (iNOS), thus resulting 
in the production of a large amount of NO. A 
histochemical study demonstrated that NO damaged 
bronchial epithelial cells, and thereby apparently 
inducing pneumonitis. In the case of a latent infection, 
when viral DNA was detected in the host in spite of the 
absence of any infectious particle, NO increased the 
amount of persistently-infected MCMV-DNA. As a 
result, NO was found to act as "a double edged sword" 
in the CMV-host relationship. 
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Furchgott, Ignarro and Moncada revealed that 
Endothelial cell relaxing factor (EDRF) was actually 
nitric oxide (NO). Thereafter, the development of 
various methods to measure NO and its derivatives, 
identification of NO synthases (NOS), syntheses of 
various NO inhibitors and the making of NOS gene- 
targeting mice has allowed us to identify numerous roles 
of NO in various fields of biology (MackMicking et al., 
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NO is a highly reactive radical formed from L- 
arginine, a semi-essential amino acid, by the action of 
NOS, which possesses 3 isoforms; neurona1 NOS 
(nNOS, NOS- l ) ,  inducible (¡NOS, NOS-2), and 
endothelial NOS (eNOS, NOS-3). The enzymatic 
activities of nNOS and eNOS require ca2+,  whereas 
iNOS acts in a Ca-independent way. The iNOS can be 
induced in various cel ls  including macrophages, 
endothelial cells, epithelium cells and mesangium cells, 
by such cytokines as TNF-a and IFN-y, and bacteria1 
endotoxins. In general, iNOS can produce a higher 
amount of NO than other isoforms of NOS. NO spreads 
by diffusion, and then passes through the cell membrane 
without requiring any specific receptor on it, and finally 
reaches its target molecule. Although NO was originally 
found to be a physiologically indispensable material, it is 
now well recognized that NO, especially that derived 
from iNOS, can also damage normal tissues. As a result, 
NO is therefore now considered to be a double-edged 
sword. 
Various reports from many laboratories have been 
published regarding the various roles of NO in viral 
infections. When the virus infects the host, several anti- 
viral cytokines are produced in the early stages of 
infection. Type 1 interferons (IFN a/B) are produced by 
the infected cells, and IFN-y and T N F - a  are then 
released from NK cells and/or T cells. Although the 
direct anti-viral effect of IFN-y is weaker than that of 
Type 1 interferons, IFN-y is a strong activator of iNOS. 
In addition, TNF-a demonstrates a synergistic effect 
with IFN-y to induce iNOS. Sequentially, a large amount 
of NO is produced by iNOS. The purpose of this article 
is to demonstrate the various aspects of NO in viral 
infections. However, NO has been reported to have 
various roles in various virus infections (Reiss et al., 
1998). We therefore focused our attention on one virus, 
cytomegalovirus (CMV). 
Human CMV (HCMV) is a DNA virus, which 
belongs to B-Herpesvirinae of Herpesviridae. HCMV 
infection is endemic in almost al1 human populations. 
For example, around 90% of adults are seropositive in 
Japan. Primary HCMV infection, which mainly occurs 
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in childhood, is usually asymptomatic. Similar to other 
herpes viruses, the primary HCMV infection is followed 
by a persistent or latent infection. The persistently or 
latently infected HCMV seldom causes severe infectious 
disease in an immunocompetent host. However, in 
immunocompromised patients,  especially in 
immunocompromised hosts such as developing fetuses, 
AIDS patients and organ transplant recipients, the 
primary infection or reactivation of the virus may cause 
various inflammatory diseases such as encephalitis, 
pneumonitis, rentinitis, hepatitis, gastritis, and colitis. 
CMV is thus considered to be one of the most important 
microorganisms in opportunistic infections. In addition, 
the number of AIDS patients and transplant recipients 
has dramatically increased in developing and advanced 
countries,  respectively. Such increases in 
immunocompromised patients raise severe concerns 
about CMV infection. 
Al1 of the results shown in this article were obtained 
in experiments using mouse CMV (MCMV). Although 
MCMV cannot infect to humans, it resembles its human 
counterpart, HCMV, in many ways with respect to the 
establishment of acute and chronic infection, vira1 
persistency and latency, and host-virus interaction 
(Hudson,  1979). In this review article,  we have 
demonstrated the roles of NO in protection during the 
early s tage of primary MCMV infection, in the 
pathogenesis of CMV-mediated pneumonitis, and in 
MCMV latency (Fig. 1). 
Role of NO in early stage of primary CMV infection 
In HCMV primary infection, the virus usually 
spreads throughout a population by direct or indirect 
person-to-person contact (Britt et al., 1996). In such 
cases, the sources of the virus are the secretions from the 
infected patients such as saliva, urine, cervical and 
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Fig. 1. A schernatic representation dernonstrating the various effects of 
nitric oxide (NO) in rnurine cytornegalovirus (MCMV) infections including 
acute, persistent and latent infection. 
vagina1 secretions, semen, breast milk, urine, tears, feces 
and blood. Following a primary HCMV infection, the 
virus enters the bloodstream. Though it has yet to be 
elucidated as to how the virus enters the bloodstream, 
HCMV-DNA can be detected in leukocytes such as 
monocytes, lymphocytes and neutrophils (Bruggeman, 
1993). Using the leukocytes as vehicles, HCMV spreads 
to various organs including the salivary glands, kidney, 
liver, spleen, heart, lungs, intestines and so on (Sinzger 
et al., 1996). 
In the mouse model of CMV infection, a mouse is 
usually infected with MCMV via the intraperitoneal (ip) 
route. It was previously reported that ip-inoculated 
MCMV replicated in macrophages and mesothelial cells 
in the peritoneal cavity (Stoddart et al., 1994). 
Thereafter, the virus disseminated to various organs such 
as the spleen, livers, and so on, using the mononuclear 
phagocytes as the vehicles. As a result, although the 
infection route is completely different from that in a 
clinical setting, MCMV by ip infection disseminates in a 
host in a way similar to that of HCMV. Therefore, the 
acute injection of MCMV by an ip injection of the virus 
is considered to be an appropriate acute infection model 
of HCMV. 
The immune responses to acute infection can be 
classified into two categories: the innate response in the 
early phase and the specific response in the late phase 
(Ahmed et al., 1999). In innate immunity against 
MCMV infection, NK cells (Bukowski et al., 1984; 
Welsh et al., 1991), macrophages (Selgrade et al., 1979; 
Hamano et al., 1998), and cytokines collaboratively 
work together as the first line of anti-MCMV. In specific 
immunity, CD4+ T cells, CD8+ T cells, and antibody act 
to eliminate the virus, thus resulting in a protective effect 
on the virus-associated pathogenesis (Reddehase et al., 
1987; Jonjic et al., 1989). Proinflammatory cytokines 
such as IFN-y and TNF-a,  are also involved in the 
elimination of MCMV both in the early and a late phase 
of infection (Lucin et al., 1994; Heise et al., 1995; Presti 
et al., 1998). Especially, IFN-y has been shown to play 
an important role against MCMV (Lucin et al., 1992; 
Orange et al., 1995, 1996). 
It has recently been demonstrated that not only the 
anti-vira1 cytokines but also macrophage-derived NO, 
which is mainly produced by an iNOS-dependent 
pathway, participates in anti-virus mechanism (Ahmed et 
al., 1999). We thus examined the role of the ¡NOS- 
dependent pathway in the early stage of MCMV primary 
infection by using an iNOS-gene knock-out 
mouse  NOS-1-) together with its l i t termate 
([C57BL/6~129/SvEv] F1, ¡NOS+/+) (Noda et al., 2001). 
When, lx lo5  plaque-forming unit (PFU, an indicator of 
a number of productive virus) of MCMV was ip 
infected, the ¡NOS-1- mice were more susceptible to a 
lethal infection with MCMV than the iNOS+/+ mice 
(Fig. 2). In addition, the  NOS-1- mice generated a much 
higher peak virus titer in the salivary gland, which was 
the main organ of MCMV replication after primary 
infection (LoglO PFU/organ =10.5 at 4wk post infection 
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Table 1. Models of MCMV pneurnonlis. 
SlTE OF MCMV INFECTION INDUCTION OF PNEUMONITIS REFERENCE 
Peritoneal cavity (B1OxBlOBR)Fl GvH Grundy et al., 1985 
Nasal cavity BALBIc Cyclophospharnide Shanley et al., 1985 
Foot pad BALBIc y-irradiation Reddehase et al., 1985 
Peritoneal cavity BALBIc anti-CD3 injection Tanaka et al., 1994 
MCMV: rnurine cytornegalovirus 
vs. 6.3 at 2wk post infection in iNOS+/+ mice). The 
titers of MCMV in other organs, such as the lung and the 
spleen increased slightly more in  NOS-1- mice than in 
iNOS+/+ mice. NK cell cytotoxicity and CTL response 
in ~ 0 ~ 2 - 1 -  mice were comparable to those of NOS2+/+ 
mice. In an in vitro analysis, the peritoneal macrophages 
from  NOS-1- mice exhibited a lower antiviral activity 
than those from iNOS+/+ mice in spite of the presence of 
a similar phagocytic activity, thus resulting in an 
enhanced viral replication in these cells. The treatment 
of macrophages from NOS2+/+ mice with a selective 
NOS2 inhibitor, (2-mercaptoethy1)-guanine (MEG), 
decreased the antiviral activity to a leve1 below that 
obtained with  NOS-1- mice. The iNOS-mediated 
antiviral activity of macrophages via NO was thus 
considered to play a protective role against MCMV 
infection at an early stage of primary infection (Fig. 3). 
Although primary CMV infection only causes severe 
infectious diseases in immunocompromised individuals, 
the origin of CMV in these patients frequently derived 
from a latently/persistently infected virus. We also 
examined the role of iNOS in latent MCMV infection, 
which was determined as the presence of viral DNA 
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Flg. 2. The effect of NO on the survival rates in mice infected with 1x105 
pfu of MCMV. To examine the anti-viral effect of NO, which is rnainly 
produced by inducible NO synthase (¡NOS), ¡NOS-gene knock-out rnice 
(¡NOS-1-) and their litterrnates (¡NOS+/+) were used (n=6-8). The 
survival rates were observed until 15 days afier infection. 
without any infectious particles. As a result, we observed 
that MCMV-DNA was detected up to 32 wk after the 
primary infection in the lungs of *OS-1- mice, whereas 
the viral DNA could not be detected even 2 wk after 
infection in the lungs of NOS2+/+ mice (Noda et al., 
2001). iNOS was thus considered to play a significant 
role not only in the initial clearance of the primary 
infection, but also in its latency following a primary 
infection. It is thus plausible that the viral burden load in 
the early stage of primary infection may regulate the 
viral load of latency. 
Pathogenesis of CMV-mediated pneumonitis 
CMV-associated pneumonitis is a serious concern 
because of its high frequency of occurrence and high 
mortality in immunocompromised patients. CMV can 
damage the tissues in the organs, including the lung, 
liver, intestine, stomach, retina and the brain. The 
damage in various organs, except the lungs, has been 
believed to result from direct viral cytopathogenecity, 
although the mechanism for this is unclear. Anti-CMV 
agents,  such a s  ganciclovir, which inhibits DNA 
replication of CMV, are effective for CMV infection in 
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Flg. 3. A schernatic representation dernonstrating the role of NO in anti- 
MCMV innate imrnunity. Regarding innate irnrnunity, rnacrophage- 
derived NO played a protective role against MCMV. Such cytokines as 
IFN-dR and IFN-y also act as anti-MCMV factors. In addiion, NK cells 
have been reported to be irnportant cells in the protection against a 
prirnary infection of MCMV. 
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organs other than the lungs. In AIDS patients with 
severe immunosuppression, CMV causes infection in 
various organs. However, CMV-pneumonitis i s  
surprisingly rare in these patients. In addition, in clinical 
organ transplantation, such immunological responses as 
rejection episodes, GVHD (graft-vs-host disease), and 
infections may trigger CMV pneumonitis. Moreover, 
vira1 replication in the lung has not been suggested to be 
related to the onset of CMV pneumonitis and the host 
immune system participated in the pathogenesis of the 
disease. These clinical observations thus suggest that 
CMV pneumonitis is not due to virus replication but 
instead is caused by some irnmune-mediated mechanism 
(Zaia, 1991). 
Several models of MCMV pneumonitis have been 
demonstrated (Table 1). In the first model, unirradiated 
F1 hybrid mice infected with MCMV developed severe 
interstit ial pneumonitis,  when spleen cel ls  were 
adoptively transferred from an uninfected parental 
Expression levels of mRNA in the spleen cells 
of MCMV-infected mice treated with anti-CD3 
Fig. 4. The expression of cytokine mRNA analyzed by RNA-PCR 
(agarose gel electrophoresis). The mice, which had been infected 
intraperitoneally with LD50 (50% lethal dose) of MCMV 4 wk earlier, 
were injected with 50pg of anti-CD3 monoclonal antibody (clone; 145- 
2C11). The lungs were removed at 0,3, 6, and 12 hrs after the antibody 
injection to extract RNA. The expression of mRNA for the cytokines and 
the control (8-actin) were examined by RNA-PCR. Commercially 
available primers were used. The RNA-PCR products were stained with 
ethidium-bromide. FX174lHaelll digest was used as a base pair marker. 
mouse strain (Grundy et al., 1985). In this model, 
MCMV infection alone, or the induction of GVH (graft- 
vs-host) reaction alone could not lead to pneumonitis. In 
the second model,  a s ingle injection of 
cyclophosphamide 24 hr after the intranasal injection of 
MCMV provoked interstitial pneumonitis (Shanley et 
al., 1985). In this model of MCMV pneumonitis, 
interstit ial pneumonitis stil l  remained even after 
reductions in the MCMV titers after administration of 
acyclovir or anti-MCMV serum. In the third model, 
Reddehase et al. (1985) successfully induced MCMV 
pneumonia in y-irradiated BALB/c mice. The fourth 
model of MCMV pneumonitis was reported by our 
group (Tanaka et al., 1994). Adult BALB/c mice were 
intraperitoneally infected with 0.2 LD50 (50% lethal 
dose) of murine cytomegalovirus (MCMV). At 4 wk 
after the infection, MCMV remained detectable only in 
the salivary glands, but not in the lungs or other organs. 
When the T cells of these mice were then activated in 
vivo by a single injection of anti-CD3 monoclonal 
antibody (mAb), interstitial pneumonitis was thus 
induced in lungs that were free of the virus with an 
excessive production of the cytokines. In the lungs of 
such mice persistently infected with MCMV, the mRNA 
of the cytokines such as IL-2, IL-6, TNF-a and IFN-y 
were abundantly expressed 3 hr after the anti-CD3 
injection, and the elevated levels continued thereafter 
(Fig. 4). A marked expression of iNOS was then noted in 
the lungs, thus suggesting that such cytokines as TNF-a 
and IFN-y induced iNOS (Tanaka et al., 1997). To 
confirm whether MCMV-associated pneumonitis was 
attributed to iNOS-derived NO,  NOS-1- mice were 
utilized. As mentioned above,  NOS-1- were sensitive to 
MCMV. The MCMV genome thus still remained in 
some lungs even at 4 wk after the injection of 0.2LD50 
of MCMV (Fig. 5A). In spite of such a high amount of 
MCMV-DNA, none of  NOS-f- died after anti-CD3 mAb 
injection (Fig. 5B). 
Although, NO itself can moderately damage the 
tissues, peroxynitrite (ONOO-), an intermediate 
molecular species formed by the rapid reaction of NO 
with 02- or OCIO-, has been considered to be a major 
molecule in NO-mediated tissue injury (Crow et al., 
1995). Evidence for the role of peroxynitrite in vivo is 
largely based on the detection of 3-nitrotyrosine in 
injured tissue (Kaur et al., 1994; Kooy et al., 1995; Saleh 
et al., 1997). An immunochemical analysis was done to 
examine the cel ls  injured through NO-mediated 
cytotoxicity. As  a result,  nitrotyrosine was 
homogeneously detected in the bronchiolar epithelial 
cells (Tanaka et al., 2001). iNOS has been previously 
reported to be abundant in airway epithelial cells (Barnes 
et al., 1993; Asano et al., 1994; Robbins et al., 1994). 
Since the bronchiolar epithelial cells align in the 
respiratory tract, which is constantly exposed to an 
externa1 environment, it is logical that both iNOS 
molecules and their activities would be abundant in 
respiratory epithelial cells in order to protect the host 
from invasive microorganisms. However, NO derived 
NO in CMV infection 
from iNOS is also known to act in some cases as "a 
double-edged sword". In the case of MCMV infection, 
T-cells in infected mice are modified as to release 
supraphysiological amounts of cytokines. This  
modification thus allows the bronchiolar epithelial cells 
to induce high amounts of iNOS, which results in NO- 
mediated cytotoxicity in the epithelial cel ls  and 
surrounding tissue (Fig. 6) 
Which kind of modification occurs in the T cells of 
MCMV-infected mice? As shown in Fig. 4, anti-CD3 
mAb induced a transient expression of mRNA of various 
cytokines 3 hr after the antibody injection in the spleen 
cells of mock-infected mice. Thereafter, no such 
expression levels of mRNA were detected, thus 
suggesting that some feedback signals were presumably 
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Flg. 5. The detection of MCMV-immediate early (IE) genome by PCR 
(A) and the mortality of the mice following anti-CD3 monoclonal 
antibody injection (8). A. ¡NOS-gene disrupted mice (~Nos-I-) and their 
wild type controls (¡NOS+/+) were intraperitoneally infected with 
0.2LD50 of MCMV. Four wk after infection, DNA was extracted and 
PCR was done. The PCR products were electrophoresed in agarose 
gel. One pg of pAMB25, a plasmid which included a whole irnmediate 
early (IE) segment of MCMV-DNA, was used as a positive control. Note 
that MCMV-DNA was detected in half of the lungs of ¡NOS-/- mice. 
B. The mice, which had been infected with 0.2LD50 of MCMV at 4 wk 
induced in the T cells from uninfected mice to terminate 
the positive activation. In contrast, anti-CD3 mAb 
induced a high expression of mRNA of such cytokines 
as IL-2, IL-6, TNF-a and IFN-y starting 3 hr after mAb 
injection, and such high levels thereafter continued until 
12 hr in the cells from MCMV-infected mice (Fig. 4). 
These results suggested that the feedback signal 
pathways were impaired in the T cells of MCMV- 
infected hosts, and thus those activation states were 
prolonged in these cells. 
Although the precise mechanism regarding how anti- 
CD3 mAb provokes MCMV-pneumonitis remains 
unclear, it is interesting to note that neither a permissive 
virus nor even vira1 DNA could be detected in T cells or 
the lung tissue of our  mouse model of MCMV- 
pneumonitis. These results suggested that a modification 
of T cells in MCMV-infected mice was induced not by 
MCMV but by the host's immune responses against 
MCMV. We previously observed such an effect of 
MCMV in  other cell  populations including the 
thymocytes and hematopoietic progenitor cells. In the 
T-cell mediated pneumonitis in 
MCMV-infected mice 
T cell activation 
Activation of cytokine cascade 
Massive cytokines (TNF- a, IFN- 7 ) release 
(Cytokine storm) 
1 Cytokine Receptor 
Bronchiolar 
Epithelium 
lnflammation & injury 
earlier, were injected with 150pg of anti-CD3 monoclonal antibody. mainly in bronchiolar epithlelial c ~ I ~ s  
Thereafter, the survival rate was obsewed until 7 d after the injection. 
Note that none of the ¡NOS-/- mice died in spite of the presence of a Flg. 6. A schernatic representation demonstrating our hypothesis on the 
large amount of MCMV-DNA (A). pathogensis of MCMV-mediated pneumonitis. 
NO in CMV infection 
mice which had been infected with MCMV 4 wk. 
before, a single injection of 20 p g  of anti-CD3 mAb 
dramatically eliminated the thymocytes by apoptosis, 
while the same dose of anti-CD3 mAb was unable to 
induce apoptosis in the thymocytes in uninfected mice 
(Koga et al., 1994). Interestingly, in the post-infection 
period, MCMV-DNA was undetectable in the 
thymocytes. Similarly, Fas-mediated apoptosis was 
enhanced in the hematopoietic progenitor cells of 
MCMV-infected mice, in which MCMV-DNA were 
undetectable (Mori et al., 1997). These results suggested 
that various types of immune cells including T cells, 
thymocytes and hematopoietic progenitor cells, were 
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Flg. 7. The detection of MCMV-DNA in the IE (A) and gH (S) regions in 
the organs of CBFl rnice, which had been inoculated 5 wk earlier with 
0.2LD50 of MCMV, after the transfer of spleen cells frorn uninfected 
BALBIc rnice. The organs were harvested at 0, 2, 4, 6 wk after the 
transfer, and thereafter DNA was extracted. One pg of the DNA was 
enhanced by PCR. The PCR product was gel eleclrophoresed, and then 
Southern blotting was perforrned using the probe labeled with the ECL 
system. A. The primer pair amplified a 700bp segrnent for the IE gene 
sequence of MCMV. 10-0.1 pg of pAMB25 was used for the positive 
controls. B. The oligonucleotide primer pairs, which were selected frorn 
the gH gene (late gene) of MCMV-DNA, arnplified the 506bp segrnent of 
the gH sequence of MCMV. The DNA extracted from the salivary glands 
of BALBIc mice, which had been infected intaperitoneally with 0.2LD50 
of MCMV 2 wk previously, was used as a positive control. 
Representative results are shown. 
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supposed to be functionally altered through host 
responses to an MCMV infection. 
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Role of NO in latent infection and reactivation of 
MCMV 
Latency and reactivation are important 
characteristics of viruses in the herpes virus family. A 
latent infection is defined as a state in which the vira1 
genome is present without producing any infectious 
particles. Reactivation means the state in which the 
latent virus becomes when producing the infectious 
particles upon some externa1 stimuli. In mice, various 
organs such as the salivary glands, brain, heat, lung, 
liver, spleen, kidney and blood have been reported as 
sites of MCMV latency. Regarding cell  types, 
endothelial cel ls  and blood cells,  which include 
polymorphonuclear cells,  macrophages and bone 
marrow cells have been reported to be the site of MCMV 
latency. In various organs, the lungs, which are rich in 
macrophages, are reportedly the major sites of CMV 
latency (Balthesen et al., 1993; Kurtz et al., 1997). 
NO has been suggested to be a major substance 
governing GVHR (graft-versus-host reaction) (Hoffman 
et al., 1996, 1997; Kichian et al., 1996; Krenger et al., 
1996). We therefore used the mouse model of GVHR to 
examine the role of NO in MCMV latency and 
reactivation in vivo. At 5 wk after the intraperitoneal 
infection of MCMV in adult (C3HIHe x BALB/c) F1 
(CBFl) mice, MCMV-DNA was mainly noted in the 
salivary glands (SG, Fig. 7A) by the assay of PCR 
(Detection limit; 1 pg of pAMB25, a plasmid integrating 
whole immediate early gene segment of MCMV). The 
detection limit corresponded to about 6 . 1 ~ 1 0 ~  copies of 
MCMV virus. When parental BALB/c spleen cells were 
then intravenously transferred to these mice to induce 
GVHR, a high copy number of MCMV DNA was thus 
observed in the lungs as well as the hearts and livers at 4 
to 6 wk after cell transfer, whereas the copy numbers in 
SG after the cell transfer were comparable to those 
before the transfer (Fig. 7A). Similar results were 
obtained in PCR using primers to enhance the late gene 
segment of MCMV (Fig. 7B), thus suggesting that 
GVHR increased the amount of the whole genome of 
latently infected MCMV from an undetectable level up 
to a detectable level (>6.1x105 copies). Since a marked 
expression of mRNA of iNOS was noted in the lungs 
and the hearts during the course of GVHR (Okada et al., 
1999), the role of NO in the increase of MCMV-DNA 
after the cell transfer was examined. To confirm that the 
increase in the MCMV genome was attributed to NO, L- 
arginine, a substrate for iNOS, and Phenyl-N-tert-butyl 
nitrone (PBN), which inhibited the induction of iNOS 
(Miyajima et al., 1995) were intraperitoneally injected to 
these mice suffering from GVHR. The administration of 
L-arginine increased the amount of MCMV DNA in the 
lungs and the hearts after the induction of GVHR (Fig. 
8A). In contrast, PBN inhibited the emergence of 
MCMV DNA (Fig. 8B). Therefore, the NO generated 
-506bp -u m m- m 1,- -(3: 
- r r - 0  - 506bp 
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during the course of GVHR increased the amount of the 
viral DNA in the lungs and the hearts of the mice 
latently infected with MCMV. However, no transcripts 
of MCMV DNA could be detected in these mice (Okada 
et al., 1999). If the increase in the amount of viral 
genome is the initial step of viral reactivation from the 
latent state, NO could thus be concluded to trigger the 
initial step of MCMV reactivation. Taken together with 
the fact that the lungs are the major organs to produce 
NO after systemic stimulation, this hypothesis may 
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Flg. 8. The effects of L-arginine (A) and PBN (8) on the amount of 
MCMV-DNA in the organs of the CBFI mice, which had been infected 
with MCMV 5 wk earlier, after the transfer of BALBIc spleen cells. The 
DNA was extracted from the lungs and the hearts of the mice at various 
times after the transfer, and then 1 pg of the DNA was enhanced by 
PCR using the primers selected from the MCMV IE gene sequence 
(700bp). The PCR product was gel electrophoresed, and then Southern 
blotting was performed using the probe labeled with the ECL system. 
pAMB25 was used as a positive control. Representative results of hivo 
independent experiments are shown. A. CBFI mice, which had been 
infected with MCMV 5 wk before, were transferred with BALBIc spleen 
cells, and then were treated with or without 5OOmg/kg/day of L-arginine, 
a substrate for ¡NOS, every 2 days until the day of sacrifice. B. CBFI 
mice, which had been infected with MCMV 5 wk before, were 
transferred with the BALBIc spleen cells, and then were treated with or 
without PBN (an inhibitor of ¡NOS induction, 3-30mg/kg/day) every 2 
days until the day of sacrifice. 
explain why the lungs are the major sites of CMV 
latency and why GVHR triggers CMV reactivation. 
Concluding remarks 
As shown in this article, NO plays various roles in 
MCMV infection. Although its protective role in the 
acute infection of MCMV and the pathogenical effect 
are comprehensive, its role in the viral latency and viral 
reactivation remains unclear. The reason for this is due 
to the fact that the mechanism of the viral latency has yet 
to be elucidated in the field of virology. We hope that 
NO provide us with a clue to solve the mechanism of 
viral latency. 
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